Hester Biosciences Limited (BOM:524669)

Hester Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	13,270	10,667	11,818	12,934	23,099	16,306
Market Cap Growth	-26.33%	-9.74%	-8.63%	-44.00%	41.66%	107.20%
Enterprise Value	15,458	13,063	14,503	15,490	24,167	17,452
Last Close Price	1559.95	1249.57	1381.11	1504.56	2675.03	1880.37
PE Ratio	32.62	38.81	62.57	48.58	58.75	47.36
PS Ratio	4.20	3.41	3.80	4.65	9.37	7.49
PB Ratio	3.78	3.27	3.90	4.48	8.64	6.91
P/TBV Ratio	4.02	3.47	4.11	4.67	8.96	7.17
P/FCF Ratio	-	24.29	49.69	-	-	94.19
P/OCF Ratio	-	16.54	24.53	54.82	265.14	28.09
EV/Sales Ratio	4.90	4.18	4.66	5.57	9.80	8.02
EV/EBITDA Ratio	19.86	21.06	24.17	24.81	33.90	24.23
EV/EBIT Ratio	25.11	28.63	33.63	36.86	43.91	29.52
EV/FCF Ratio	-	29.74	60.97	-	-	100.81
Debt / Equity Ratio	0.61	0.69	0.85	0.95	0.85	0.47
Debt / EBITDA Ratio	2.97	3.59	4.28	4.38	3.19	1.52
Debt / FCF Ratio	-	5.09	10.84	-	-	6.36
Asset Turnover	-	0.48	0.47	0.45	0.51	0.55
Inventory Turnover	-	1.27	1.24	1.03	0.99	0.84
Quick Ratio	-	0.70	0.95	0.68	0.85	1.15
Current Ratio	-	1.56	2.04	1.53	2.01	2.63
Return on Equity (ROE)	-	9.16%	7.16%	10.09%	15.69%	15.68%
Return on Assets (ROA)	-	4.33%	4.05%	4.26%	7.07%	9.26%
Return on Invested Capital (ROIC)	7.80%	6.11%	5.23%	5.76%	10.22%	12.93%
Return on Capital Employed (ROCE)	-	8.60%	7.70%	8.10%	11.80%	16.90%
Earnings Yield	3.09%	2.58%	1.60%	2.06%	1.70%	2.11%
FCF Yield	-	4.12%	2.01%	-4.19%	-3.77%	1.06%
Dividend Yield	0.45%	0.56%	0.43%	0.53%	0.37%	0.53%
Payout Ratio	-	18.80%	36.28%	31.95%	21.63%	16.31%
Buyback Yield / Dilution	0.58%	-	-	-	-	-
Total Shareholder Return	1.03%	0.56%	0.43%	0.53%	0.37%	0.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.